Dawnzera (Donidalorsen)

Dawnzera (donidalorsen) is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

Recommended Dosage:
The recommended dosage of Donidalorsen is 80 mg administered subcutaneously every 4 weeks. A dosage of 80 mg administered subcutaneously (SC) every 8 weeks may be considered.
In case a dose of Donidalorsen is missed, administer it as quickly as possible. Resume treatment at the recommended dosing frequency from the date of the most recently administered dose.

• Patients receiving treatment with Donidalorsen 80 mg/0.8 mL may experience allergic reactions ranging from rash, itching, or swelling to severe anaphylaxis. Proper monitoring is important during and after administration, and immediate emergency treatment must be available in case hypersensitivity reactions happen.
• Donidalorsen injection must not be used in individuals with a known history of life-threatening allergic reaction to this treatment or its ingredients. Contraindications also include conditions where risks outweigh potential benefits, as advised by healthcare providers.
• The safety of this medicine during pregnancy is not completely established. The medicine should only be used when clearly required, and healthcare providers (HCPs) must carefully weigh potential benefits against potential risks to the mother as well as unborn child.
• It is unknown whether this medicine passes into human breast milk. Caution is required for nursing mothers, and a decision must be made whether to stop breastfeeding or discontinue treatment, considering the potential risk to infants.
• The safety as well as effectiveness of this medicinal product in pediatric patients has not been completely established. Clinicians should exercise proper caution, and treatment decisions must be individualized depending on the severity of disease, potential benefit, and risk of side effects.
• Patients with renal impairment may need closer monitoring, as kidney function could influence the clearance of medicine. Dosage adjustments may be required, and healthcare professionals (HCPs) should assess risks as well as benefits before prescribing in this population.

What documents are required to import DAWNZERA to India?

DAWNZERA (donidalorsen) injection can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is DAWNZERA available in India?

DAWNZERA (donidalorsen injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Dawnzera in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

DAWNZERA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of DAWNZERA (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 |or write us at info@indianpharmanetwork.in for Dawnzera 80 mg/0.8 mL injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source DAWNZERA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Dawnzera®?

Donidalorsen is the Generic Name for the trade name drug Dawnzera®.

What is the Manufacturer’s Name of Dawnzera®?

Dawnzera® is manufactured by Ionis Pharmaceuticals, Inc.

Is Dawnzera approved by the FDA?

Yes. Dawnzera is approved by the FDA. date of first approval: August 21, 2025.

What is the dosage and form of Dawnzera® supplied?

Dawnzera is supplied for Injection: 80 mg/0.8 mL solution in a single-dose autoinjector for subcutaneous use.

What are the most common side effects of Dawnzera® 80 mg/0.8 mL injection?

The most commonly reported side effects of Dawnzera® upper respiratory tract infection, injection site reactions, urinary tract infection, and abdominal discomfort.

How much does Dawnzera® 80 mg/0.8 mL injection cost in India?

Dawnzera® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Dawnzera prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Dawnzera 80 mg/0.8 mL cost in India, please call/WhatsApp +91-9310090915 or send an email to info@indianpharmanetwork.in.

Can Dawnzera® 80 mg/0.8 mL injections be available in SAARC countries?

Apart from Gulf countries, Dawnzera® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Dawnzera® injection in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Dawnzera® 80 mg/0.8 mL injection online in India?

Yes, one can buy Dawnzera 80 mg/0.8 mL online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Dawnzera® injection through legal channels.

What are the storage conditions of Dawnzera® 80 mg/0.8 mL injections?

Store the Dawnzera autoinjector in the refrigerator between 36°F to 46°F (2°C to 8°C) in the original carton. It is not advisable to freeze this medicine. Do not expose to heat. Protect from direct light.